New Radioimmunotherapy Shows Promise Against HER2-Positive Breast Cancer
Research published in the November 2025 issue of the Journal of Nuclear Medicine reveals a promising new radioimmunotherapy approach for treating human epidermal growth factor receptor 2 (HER2)-positive breast cancer.…